Docgo Inc Stock Intrinsic Value – DOCGO INC Reports Third Quarter FY2023 Earnings Results on November 6, 2023
November 26, 2023
🌥️Earnings Overview
DOCGO INC ($NASDAQ:DCGO) reported their financial results for the third quarter of FY2023, which ended on September 30 2023, on November 6 2023. The total revenue for the quarter was USD 186.6 million, representing a 78.8% increase compared to the same period in the previous year. Net income also rose by 51.1%, amounting to USD 4.8 million.
Price History
DOCGO INC, a leading provider of digital document services, reported its third quarter FY2023 earnings results on Monday, November 6, 2023. Despite this increase in revenue, the stock price opened at $6.0 and closed at $5.8, down 4.0% from the last closing price of $6.0. The company attributed the drop in stock price to the competitive landscape and lower spending by corporate clients.
Overall, DOCGO INC has been able to maintain a solid financial performance despite the challenging market conditions. The company is confident that its investment in new products and services will help it achieve long-term growth and success. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Docgo Inc. More…
| Total Revenues | Net Income | Net Margin |
| 533.83 | 7.35 | 1.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Docgo Inc. More…
| Operations | Investing | Financing |
| -67.04 | -27.57 | -18.72 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Docgo Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 419.78 | 128.23 | 2.77 |
Key Ratios Snapshot
Some of the financial key ratios for Docgo Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 108.9% | – | 0.6% |
| FCF Margin | ROE | ROA |
| -14.1% | 0.8% | 0.5% |
Analysis – Docgo Inc Stock Intrinsic Value
We at GoodWhale have conducted an analysis of DOCGO INC‘s wellbeing and calculated the intrinsic value of their shares to be around $14.5. This was done using our proprietary Valuation Line. It appears that DOCGO INC stock is currently trading at $5.8, which is substantially lower than its intrinsic value, indicating that it is undervalued by 60.0%. We suggest that investors take this into consideration when considering whether to invest in DOCGO INC. More…
Peers
It offers a comprehensive suite of products and services that enable patients to receive the best possible care. The company’s products and services are designed to improve the quality of care and reduce the cost of care. DocGo Inc‘s competitors include Skylight Health Group Inc, P3 Health Partners Inc, and PT Metro Healthcare Indonesia Tbk.
– Skylight Health Group Inc ($TSXV:SLHG)
Skylight Health Group Inc is a Canadian publicly traded company that provides primary healthcare services. The company has a market cap of 25.09M as of 2022 and a Return on Equity of -54.94%. Skylight Health Group Inc operates a network of primary healthcare clinics across Ontario and Alberta. The company’s clinics offer a range of services, including family medicine, walk-in care, chronic disease management, and mental health services.
– P3 Health Partners Inc ($NASDAQ:PIII)
P3 Health Partners Inc is a healthcare technology company that provides software and services to help healthcare organizations improve the quality and efficiency of patient care. The company has a market cap of $198.75 million and a return on equity of 106.12%. P3 Health Partners is headquartered in Denver, Colorado.
– PT Metro Healthcare Indonesia Tbk ($IDX:CARE)
As of 2022, PT Metro Healthcare Indonesia Tbk has a market cap of 15.56T and a ROE of 0.73%. The company is a leading provider of healthcare services in Indonesia. It offers a wide range of services, including medical care, nursing care, and rehabilitation services. The company has a strong commitment to quality and customer satisfaction. It is one of the few companies in Indonesia that is ISO 9001:2008 certified.
Summary
DOCGO INC has reported positive results for the third quarter of FY2023, with total revenue of USD 186.6 million, a 78.8% increase and net income of USD 4.8 million, a 51.1% increase. This has been reflected in the stock price, which decreased on the news. Investors should be encouraged by the company’s strong performance and its ability to generate revenue and profits despite challenging market conditions. The increased revenue signals higher demand for the company’s products and services, and if it is able to sustain its performance over the next few quarters, DOCGO INC could be an attractive investment opportunity.
